- Home
- VNDA vs LEGT Comparison
VNDA vs LEGT Comparison
Compare VNDA & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- LEGT
- Stock Information
- Founded
- VNDA 2002
- LEGT 2023
- Country
- VNDA United States
- LEGT United States
- Employees
- VNDA N/A
- LEGT N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- LEGT
- Sector
- VNDA Health Care
- LEGT
- Exchange
- VNDA Nasdaq
- LEGT Nasdaq
- Market Cap
- VNDA 257.8M
- LEGT 268.6M
- IPO Year
- VNDA 2006
- LEGT 2024
- Fundamental
- Price
- VNDA $4.43
- LEGT $10.38
- Analyst Decision
- VNDA Strong Buy
- LEGT
- Analyst Count
- VNDA 2
- LEGT 0
- Target Price
- VNDA $16.50
- LEGT N/A
- AVG Volume (30 Days)
- VNDA 640.7K
- LEGT 18.2K
- Earning Date
- VNDA 02-13-2025
- LEGT 01-01-0001
- Dividend Yield
- VNDA N/A
- LEGT N/A
- EPS Growth
- VNDA N/A
- LEGT N/A
- EPS
- VNDA N/A
- LEGT 0.32
- Revenue
- VNDA $198,772,000.00
- LEGT N/A
- Revenue This Year
- VNDA $16.07
- LEGT N/A
- Revenue Next Year
- VNDA $24.42
- LEGT N/A
- P/E Ratio
- VNDA N/A
- LEGT $0.69
- Revenue Growth
- VNDA 3.18
- LEGT N/A
- 52 Week Low
- VNDA $3.71
- LEGT $10.00
- 52 Week High
- VNDA $6.75
- LEGT $10.47
- Technical
- Relative Strength Index (RSI)
- VNDA 44.53
- LEGT N/A
- Support Level
- VNDA $4.34
- LEGT N/A
- Resistance Level
- VNDA $4.65
- LEGT N/A
- Average True Range (ATR)
- VNDA 0.21
- LEGT 0.00
- MACD
- VNDA -0.01
- LEGT 0.00
- Stochastic Oscillator
- VNDA 36.51
- LEGT 0.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.